Kahn, Steven E.

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

Kahn, S. E., Verchere, C. B., Andrikopoulos, S., Asberry, P. J., Leonetti, D. L., Wahl, P. W., Boyko, E. J., Schwartz, R. S., Newell-Morris, L., & Fujimoto, W. Y. (1998) · Diabetes

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 74

Diet-Induced Weight Loss Is Associated with an Improvement in β-Cell Function in Older Men

Utzschneider, K. M., Carr, D. B., Barsness, S. M., Kahn, S. E., & Schwartz, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 73

Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes

van Genugten, R. E., Utzschneider, K. M., Tong, J., Gerchman, F., Zraika, S., Udayasankar, J., Boyko, E. J., Fujimoto, W. Y., Kahn, S. E., & and the American Diabetes Association GENNID Study Group (2006) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsMenopause: Health Impacts and Treatments

Cited by 73

Lack of durable improvements in β-cell function following withdrawal of pharmacological interventions in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes

The RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 73

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

A Reduced-Fat Diet and Aerobic Exercise in J apanese A mericans With Impaired Glucose Tolerance Decreases Intra-Abdominal Fat and Improves Insulin Sensitivity but not β-Cell Function

Carr, D. B., Utzschneider, K. M., Boyko, E. J., Asberry, P. J., Hull, R. L., Kodama, K., Callahan, H. S., Matthys, C. C., Leonetti, D. L., Schwartz, R. S., et al. (2005) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 69

Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: secondary analysis of the CARMELINA randomized trial

Perkovic, V., Toto, R., Cooper, M. E., Mann, J. F. E., Rosenstock, J., McGuire, D. K., Kahn, S. E., Marx, N., Alexander, J. H., Zinman, B., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 62

Effects of intensive lifestyle intervention on all-cause mortality in older adults with type 2 diabetes and overweight/obesity: results from the Look AHEAD Study

Look AHEAD Research Group, Wing, R. R., Bray, G. A., Cassidy-Begay, M., Clark, J. M., Coday, M., Egan, C., Evans, M., Foreyt, J. P., Glasser, S., et al. (2022) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 61

Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

Perreault, L., Pan, Q., Aroda, V. R., Barrett-Connor, E., Dabelea, D., Dagogo-Jack, S., Hamman, R. F., Kahn, S. E., Mather, K. J., Knowler, W. C., et al. (2017) · Diabetic Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 55

Physical function following a long-term lifestyle intervention among middle aged and older adults with type 2 diabetes: the Look AHEAD study

Houston, D. K., Neiberg, R. H., Miller, M. E., Hill, J. O., Jakicic, J. M., Johnson, K. C., Gregg, E. W., Hubbard, V. S., Pi-Sunyer, X., Rejeski, W. J., et al. (2018) · The Journals of Gerontology: Series A

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 52

Insulin and Amylin Release Are Both Diminished in First-Degree Relatives of Subjects With Type 2 Diabetes

Knowles, N. G., Landchild, M. A., Fujimoto, W. Y., & Kahn, S. E. (2002) · Diabetes Care

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 51

Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS)

Diabetes Prevention Program (DPP) Research Group, Hamman, R. F., Horton, E., Barrett-Connor, E., Bray, G. A., Christophi, C. A., Crandall, J., Florez, J. C., Fowler, S., Goldberg, R., et al. (2015) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 46

Weight change 2 years after termination of the intensive lifestyle intervention in the Look AHEAD study.

Look AHEAD Research Group, Chao, A. M., Wadden, T. A., Berkowitz, R. I., Blackburn, G., Bolin, P., Clark, J. M., Coday, M., Curtis, J. M., Delahanty, L. M., et al. (2020) · Obesity

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 40

Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial

Wexler, D. J., de Boer, I. H., Ghosh, A., Younes, N., Bebu, I., Inzucchi, S. E., McGill, J. B., Mudaliar, S., Schade, D., Steffes, M. W., et al. (2023) · JAMA Internal Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 39

Lifestyle and metformin ameliorate insulin sensitivity independently of the genetic burden of established insulin resistance variants in Diabetes Prevention Program participants

Hivert, M.-F., Christophi, C. A., Franks, P. W., Jablonski, K. A., Ehrmann, D. A., Kahn, S. E., Horton, E. S., Pollin, T. I., Mather, K. J., Perreault, L., et al. (2016) · Diabetes

Genetic Associations and EpidemiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 38

Impact of Gastric Banding Versus Metformin on β-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes

Xiang, A. H., Trigo, E., Martinez, M., Katkhouda, N., Beale, E., Wang, X., Wu, J., Chow, T., Montgomery, C., Nayak, K. S., et al. (2018) · Diabetes Care

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 37

Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study

Brancati, F. L., Evans, M., Furberg, C. D., Geller, N., Haffner, S., Kahn, S. E., Kaufmann, P. G., Lewis, C. E., Nathan, D. M., Pitt, B., et al. (2012) · Clinical Trials

Statistical Methods in Clinical TrialsStatistical Methods in Epidemiology

Cited by 34

Changes in insulin sensitivity, glucose effectiveness, and B-cell function in regularly exercising subjects

Prigeon, R. L., Kahn, S. E., & Porte, D. (1995) · Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and Health

Cited by 30

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Glucose Stimulates and Potentiates Islet Amyloid Polypeptide Secretion by the B-Cell

Kahn, S., Fujimoto, W., D'Alessio, D., Ensinck, J., & Porte, D. (1991) · Hormone and Metabolic Research

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 28

The Influence of Rare Genetic Variation in SLC30A8 on Diabetes Incidence and β-Cell Function

Billings, L. K., Jablonski, K. A., Ackerman, R. J., Taylor, A., Fanelli, R. R., McAteer, J. B., Guiducci, C., Delahanty, L. M., Dabelea, D., Kahn, S. E., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism

Genetic Associations and EpidemiologyDiabetes and associated disorders

Cited by 27

Variation in maturity-onset diabetes of the young genes influence response to interventions for diabetes prevention

Billings, L. K., Jablonski, K. A., Warner, A. S., Cheng, Y.-C., McAteer, J. B., Tipton, L., Shuldiner, A. R., Ehrmann, D. A., Manning, A. K., Dabelea, D., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism

Genetic Associations and EpidemiologyDiabetes and associated disorders

Cited by 20

Effects of combination of change in visceral fat and thigh muscle mass on the development of type 2 diabetes

Han, S. J., Kim, S.-K., Fujimoto, W. Y., Kahn, S. E., Leonetti, D. L., & Boyko, E. J. (2017) · Diabetes Research and Clinical Practice

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 17

Weight Change During the Postintervention Follow-up of Look AHEAD

Wing, R. R., Neiberg, R. H., Bahnson, J. L., Clark, J. M., Espeland, M. A., Hill, J. O., Johnson, K. C., Knowler, W. C., Olson, K., Steinburg, H., et al. (2022) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 14